Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-19-049927
Filing Date
2019-09-17
Accepted
2019-09-17 18:22:04
Documents
2
Period of Report
2019-09-16

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2231
2 POA DOCUMENT poa.txt EX-24.3_872751 3201
  Complete submission text file 0001209191-19-049927.txt   6915
Mailing Address 1900 POWELL ST., SUITE 1000 EMERYVILLE CA 94608
Business Address 1900 POWELL ST., SUITE 1000 EMERYVILLE CA 94608 510-450-3554
Adamas Pharmaceuticals Inc (Issuer) CIK: 0001328143 (see all company filings)

EIN.: 421560076 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O RETROPHIN, INC. 12255 EL CAMINO REAL, SUITE 250 SAN DIEGO CA 92130
Business Address
McFarlane Neil F. (Reporting) CIK: 0001681098 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36399 | Film No.: 191097957